Contineum Therapeutics, Inc.
CTNM$12.34▼ 1.12% 24h
Contineum Therapeutics, Inc.CTNM$12.34
+$6.50(+111.41%)Past Year
Jun 25Sep 25Dec 25Mar 26Jun 26
Key statistics
Market cap
$319.25M
P/E ratio
—
EPS (diluted)
$-2.17
Dividend yield
0.00%
Dividend / share
$0.00
Revenue
$0
Net income
$-59.98M
Net margin
—
Gross margin
—
Dividends & financials
Contineum Therapeutics, Inc. (CTNM) reported revenue of $0 and net income of $-59.98M, or $-2.17 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.